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Abstract  
Electrical synapses in the mammalian central nervous system (CNS) are increasingly 
recognized as highly complex structures for mediation of neuronal communication, both with 
respect to their capacity for dynamic short and long-term modification in efficacy of synaptic 
transmission and their multi-molecular regulatory and structural components. These two 
characteristics are inextricably linked, such that understanding of mechanisms that contribute 
to electrical synaptic plasticity requires knowledge of the molecular composition of electrical 
synapses and the functions of proteins associated with these synapses. Here, we provide 
evidence that the key component of gap junctions that form the majority of electrical 
synapses in the mammalian CNS, namely connexin36 (Cx36), directly interacts with the 
related E3 ubiquitin ligase proteins Ligand of NUMB protein X1 (LNX1) and Ligand of 
NUMB protein X2 (LNX2). This is based on immunofluorescence co- localization of LNX1 
and LNX2 with Cx36-containing gap junctions in adult mouse brain vs. lack of such co-
association in LNX null mice, co-immunoprecipitation of LNX proteins with Cx36, and pull-
down of Cx36 with the second PDZ domain of LNX1 and LNX2. Further, co-transfection of 
cultured cells with Cx36 and E3 ubiquitin ligase-competent LNX1 and LNX2 isoforms led to 
loss of Cx36-containing gap junctions between cells, whereas these junctions persisted 
following transfection with isoforms of these proteins that lack ligase activity. Our results 
suggest that a LNX protein mediates ubiquitination of Cx36 at neuronal gap junctions, with 
consequent Cx36 internalization, and may thereby contribute to intracellular mechanisms that 
govern the recently identified modifiability of synaptic transmission at electrical synapses.  
 
Introduction  
Gap junctions formed between apposing cells by various members of the family of twenty 
connexin proteins mediate gap junctional intercellular communication, where junctional 
channels allow cell- to-cell passage of ions and small molecules (Goodenough & Paul, 2009). 
Such junctions between neurons in the central nervous system (CNS) provide for direct 
electrical neuronal communication and are the morphological basis of electrical synapses 
(Bennett, 1997; Bennett & Zukin, 2004). In the mammalian CNS, neuronal gap junctions 
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formed by connexin36 (Cx36) are widely distributed (Condorelli et al., 2000; Nagy et al., 
2018), and have critically important functions in establishing synaptic circuitry during 
development (Miller & Pereda, 2017) and in facilitating synchronous neuronal activity in 
mature brain (Hormuzdi et al., 2004; Connors, 2009). It has recently been recognized that 
electrical synapses are highly dynamic, with reports indicating that neuronal communication 
mediated by these synapses is subject to modification by a variety of processes. These 
include regulation of electrical coupling by various neurotransmitters (Nagy et al., 2018), by 
the state of neuronal activity (Haas et al., 2011), by connexin phosphorylation (Urschel et al., 
2006; Kothmann et al., 2009; O’Brien, 2014) and by ion-mediated gating of Cx36-containing 
channels (Palacios-Prado et al., 2013, 2014). Importantly, such regulation has a functional 
impact on the behaviour of neuronal networks interconnected by electrical synapses in neural 
circuitry (Bloomfield & Volgyi, 2009; Pereda et al., 2013; Pereda, 2014; Haas et al., 2016; 
Curti & O’Brien, 2016). 
 The exact mechanisms underlying modulation of the strength of electrical coupling are 
not fully understood, but one possibility is via regulated trafficking of Cx36 into and out of 
gap junctions via exocytosis and endocytosis of Cx36 channels (Pereda et al., 2013; Pereda, 
2014). Such trafficking has been documented at vertebrate electrical synapses, and 
interference with this process rapidly altered electrical coupling (Flores et al., 2012), which is 
consistent with the high turnover rate of Cx36, estimated to be ~1-3 hr (Flores et al., 2012; 
Wang et al., 2015) and is similar to that of other connexins (Evans & Martin, 2002; Berthoud 
et al., 2004). Such trafficking presumably occurs via processes governing Cx36 removal and 
disposal, which for most connexins are poorly understood, with the exception of connexin43 
(Cx43) that undergoes ubiquitination and degradation by the proteasome pathway (Berthoud 
et al., 2004; Kjenseth et al., 2010; Herve et al., 2012). The attachment of ubiquitin to target 
proteins is a common cellular sorting mechanism for determination of protein fate along the 
endocytotic and exocytotic pathways (Deshaies & Joazeiro, 2009). Ubiquitination involves 
the covalent linkage of ubiquitin to lysine residues of target proteins. This process occurs via 
a stepwise enzyme cascade that requires three distinct enzyme participants; a ubiquitin-
activating enzyme (E1), a ubiquitin-conjugating enzyme (E2) and a ubiquitin- ligase (E3). The 
E3 ligase in this cascade determines target-protein specificity, and over 600 E3 ligases have 
been identified and distinguished by characteristics of their catalytic domain, which include 
the HECT, RING and U-box family of proteins (Bhoj and Chen, 2009). Many RING domain 
E3 ligases contain additional domains required for their specific interaction with target 
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proteins, including PDZ (PSD-95, DlgA, ZO-1) domains that mediate interaction with the 
PDZ ligand of their target proteins (Ye & Zhang, 2013).  
 We previously reported that Cx36 contains a PDZ domain interaction motif, consisting 
of a SAYV amino acid sequence at its carboxy-terminus, that mediates its interaction with the 
PDZ domains of various proteins, including the first PDZ domains of zonula occludens (ZO) 
proteins ZO-I, ZO-2, ZO-3, the tenth PDZ domain of multi-PDZ domain protein1 (MUPP1) 
and the single PDZ domain in AF6 (aka, afadin) (Li et al., 2004a,b, 2009, 2012). This 
carboxy-terminus SAYV PDZ ligand is contained in other proteins (e.g., claudin-1 and 
CD8α), where it mediates protein-protein interaction for ubiquitination by specific E3-
ubiquitin ligases, namely, Ligand of NUMB protein X1 (LNX1) and Ligand of NUMB 
protein X2 (LNX2) (Takahashi et al., 2009; D'Agostino et al., 2011). This raised the 
possibility of Cx36 interaction with LNX1 and/or LNX2. These two related proteins are 
RING domain E2-dependent E3 ubiquitin ligases whose PDZ domains are required for 
mediation of interactions with proteins targeted for ubiquitination. They share identical 
domain structure comprised of one amino-terminal RING domain and four PDZ domains 
(Rice et al., 2001). Each of the four PDZ domains of LNX1 and LNX2 interact with specific 
classes of PDZ ligands (Wolting et al., 2011; Lenihan et al., 2017a). LNX2 is expressed in 
many tissues, including adult brain (Rice et al., 2001; Lenihan et al., 2014). More complex is 
LNX1, where three protein isoforms have been identified; a full- length form containing the 
RING finger catalytic domain (LNX1p80), an alternatively spliced form devoid of this 
domain and thus lacking catalytic activity (LNX1p70), and a novel recently characterized 
LNX1p62 brain isoform also lacking the catalytic domain (Dho et al., 1998; Xie et al., 2001; 
Lenihan et al., 2014). In brain, LNX1p80 appears to be absent, whereas catalytically inactive 
LNX1p70 is expressed mainly in neurons and in a small subset of oligodendrocytes (Dho et 
al., 2001; Lenihan et al., 2014). 
 In order to explore means whereby Cx36 deployment, trafficking and degradation could 
contribute to the plasticity of electrical synapses, we investigated Cx36 relationships with 
LNX1 and LNX2. We examined immunofluorescence localization of these proteins in 
combination with immuolabelling for Cx36, and used molecular and biochemical approaches 
to assess Cx36/LNX interaction. 
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Materials and methods 
Animals and antibodies  
Animals were utilized according to approved protocols by the Central Animal Care 
Committee of the University of Manitoba and by the Hospital for Sick Children Animal Care 
and Use Committee, with minimization of the numbers animals used. A total of four Sprague-
Dawley rats and eight wild-type C57BL/6 mice used in this study were obtained from Central 
Animal Care Services at the University of Manitoba. In addition, the two C57BL/6 LNX1 
knockout (KO) mice used were obtained from the Toronto Centre for Phenogenomics. Brains 
from these animals were prepared and taken for immunofluorescence labelling and 
immunoblotting as described below. The LNX1 gene ablated mutant mouse strain was 
generated in the laboratory of Dr. Mark Henkemeyer (University of Texas Southwestern) as 
described (Liu et al., submitted). Briefly, LNX1 was targeted by homologous recombination 
in the R1 ES cell line, germline transmission was obtained by aggregation chimeras, and the 
LNX1 KO mice obtained were backcrossed to C57BL/6 mice for multiple generations and 
were bred and maintained under institute guidelines at the Toronto Centre for 
Phenogenomics.  
 
 Antibodies used included a mouse monoclonal anti-Cx36 (Cat. No. 39-4200) and a rabbit 
polyclonal anti-Cx36 (Cat. No. 51-6300), which were obtained from ThermoFisher 
(ThermoFisher, Rockford, Il, USA) and used at a concentration of 2-3 μg/ml. In addition, 
rabbit polyclonal anti-LNX1 and LNX2 antibodies were obtained originally from Invitrogen 
(Invitrogen, Carlsbad, CA, USA), before this provider was acquired by Life Technologies 
and then ThermoFisher. Two anti-LNX1 antibodies were generated against peptide sequences 
corresponding to amino acids 200-213 and 247-259 in LNX1, designated ab200 and ab247, 
and one anti-LNX2 antibody was generated against a peptide corresponding to amino acid 
sequence 442-458 in LNX2, designated ab442. Additional rabbit polyclonal anti-LNX1 
antibody, used for immunoblotting of LNX1 from mouse tissues and for co-IP of Cx36 with 
LNX1 from mouse brain, were generated against GST fusion proteins containing LNX1 
amino acids (aa) 8-210 and aa365-478, designated ab8 and ab365, respectively (Dho et al., 
1998). All antibodies against LNX were used at a dilution of 1:250. Mouse monoclonal anti-
His 6X-tag (Cat. No. R930) and a monoclonal rabbit anti-eGFP (enhanced green fluorescent 
protein) (Cat No. G10362) were obtained from ThermoFisher and both were used at a 
concentration of 2 g/ml, a mouse monoclonal anti-FLAG (M2) antibody (Cat. No. F1804) 
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was obtained from Millipore Sigma (Sigma-Aldrich Corp., St. Louis, MO, USA) and used at 
a dilution of 1:1000. Mouse monoclonal anti-HA tag (F-7) antibody (Cat. No. 7392) was 
obtained from Santa Cruz (Santa Cruz Biotechnology, Dallas TX, USA) and used at a 
concentration of 2 g/ml.  
 
Immunofluorescence procedures  
Procedures used here for preparation of tissue for immunofluorescence have been previously 
described in detail for immunolabelling of Cx36 in combination with other proteins (Li et al., 
2012; Lynn et al., 2012; Rubio & Nagy; 2015). Briefly, animals were first euthanized with an 
intraperitoneal injection of equithesin (3 ml per kg) and then transcardially perfused 
sequentially with a pre-fixative solution followed by a fixative solution containing buffered 
1% formaldehyde/0.2% picric acid. Cryostat sections were collected at a thickness of 15 μm 
and immunolabelled with monoclonal anti-Cx36. For double immunofluorescence labelling, 
sections were simultaneously incubated with two primary antibodies (a mouse monoclonal 
and a rabbit polyclonal: Cx36 + LNX1; Cx36 + LNX2) in a dilution buffer containing 50 mM 
Tris-HCl, pH 7.4, containing 1.5% sodium chloride and 0.3% Triton X-100 (TBSTr) 
supplemented with 5% normal  goat or normal donkey serum. Following incubation for 24 hr 
at 4C, the sections were washed for 1 h in TBSTr, and then incubated for 1.5 h at room 
temperature simultaneously with appropriate combinations of secondary antibodies diluted in 
TBSTr with normal goat or donkey serum. Secondary antibodies included Cy3-conjugated 
goat anti-mouse IgG diluted 1:500 (Jackson ImmunoResearch Laboratories, West Grove, PA, 
USA) and Alexa Flour 488-conjugated goat anti-rabbit IgG diluted 1:1000 (Molecular 
Probes, Eugene, Oregon). After secondary antibody incubations, sections were washed in 
TBSTr for 20 min, then in 50 mM Tris-HCl buffer, pH 7.4 for 30 min, covered with antifade 
medium and coverslipped. Control procedures included omission of one of the primary 
antibodies with inclusion of each of the secondary antibodies to establish the absence of 
inappropriate cross-reactions between primary and secondary antibodies.  
 
 Wide-field and confocal immunofluorescence microscopy were conducted on a Zeiss 
Axioskop2 fluorescence microscope (Carl Zeiss Canada, Toronto, Ontario, Canada) and on a 
Zeiss LSM 710 confocal microscope using ZEN software (Olympus Canada, Inc., Markham, 
ON, Canada), respectively. Figure plates were assembled using Adobe Photoshop CS (Adobe 
Systems, San Jose, CA, USA) and CorelDraw Graphics (Corel Corporation, Ottawa, ON, 
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Canada). Confocal images of double labelling of Cx36 with either LNX1 or LNX2 in brain 
sections were acquired using an oil immersion 40x objective lens with numerical aperture of 
1.4. All of the confocal images presented here were captured at a zoom factor ranging from 
3.3 to 5.5 and a resolution of 1024 x 1024 pixels, and show single scans or maximum 
intensity projection z-stacks of 2 to 7 optical scans, with a step size of 0.43 µm (defined as 
optimum for a 40x objective), giving projection thicknesses ranging from 1.72 to 3.44 µm, 
and are displayed without deconvolution. Laser illumination intensities and photomultiplier 
tube gains settings were adjusted to well below saturation of the most intense labelling 
observed to allow capture of the full range of labelling intensities and to minimize halation 
which can artificially increase the size of immunofluorescent areas of interest.  As we 
observed minimal fading of fluorescence with the laser setting chosen, the laser dwell time 
was increased to a moderate level to provide for better image quality. A total of 56 single and 
z-stack images were collected for a total of 122 images when the z-stack optical scans are 
considered separately, representing collectively all the brain regions examined. Before 
compression of the optical scans into a single image, each of the scans in a z-stack series was 
examined separately to exclude possible artifactual overlap of labelling for Cx36 with label 
for LNX that may occur from labels that were actually separated in the z-dimension. In 
addition, the image stacks were displayed in a 3-dimensional configuration, allowing 360 
degree image rotation in the x, y and z dimensions to further confirm the label for Cx36 and 
LNX remained associated at all angles of rotation.  
 
Cell culture and transfection 
HeLa cells (HeLa-WT), HeLa cells stably transfected with Cx36 (HeLa-Cx36), Neuro-2A 
(N2A) and HEK293T cells were grown in Dulbecco’s Modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum and maintained in a tissue culture incubator at 
37°C with 5% CO2. Transient transfections were conducted using Lipofectamine LTX 
transfection reagent according to manufacturer’s instructions (Invitrogen). Expression 
plasmids used for transfections included previously described LNX1p80-FLAG, LNX1p70 
and LNX2-FLAG (Nie et al., 2002). Additionally, transfection with mutant expression 
plasmids included LNX1p80C48A-FLAG and LNX2C51A-FLAG that each contains a 
functionally negative mutation within the zinc coordination site of the N-terminal RING 
domain of LNX1p80 and LNX2, which is required for ubiquitination competence (Nie et al., 
2002). A HA-ubiquitin plasmid in pcDNA3.1 was a gift from Dr. E. Yeh (Addgene plasmid # 
18712; Kamitani et al., 1997). A full- length Cx36 plasmid and a truncated Cx36Δ4 plasmid 
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that lacks coding sequence for the last four C-terminal amino acids in Cx36 (trCx36), which 
constitute its PDZ domain interaction motif, were previously described (Li et al., 2004a,b). 
C-terminal tagging of Cx36 prevents its interaction with proteins that bind the Cx36 C-
terminus. Thus, in the construct we used here (provided by Dr. S. G. Hormuzdi, University of 
Dundee), enhanced cyan fluorescent protein (eCFP) is inserted 15 amino acids upstream of 
the C-terminus PDZ ligand in otherwise full- length Cx36, freeing this ligand for interaction 
with the PDZ domains of Cx36- interacting partners. This construct was previously shown to 
form functionally communicating gap junctions (Helbig et al., 2010). Following cell 
transfection (18-20 h), cultures of cells grown on glass coverslips were washed in 50 mM 
sodium phosphate buffer, pH 7.4, containing 0.9% NaCl (PBS), fixed for 10 min in 2% 
formaldehyde in PBS, rinsed and stored at 4 °C. Immunofluorescence labelling of cells was 
conducted as described above for tissue sections. 
 
 
Western blotting 
Animals were euthanized with an intraperitoneal injection of equithesin (3 mg/kg), brains 
dissected, homogenized in 14 volumes of immunoprecipitation (IP) buffer (20 mM Tris-HCl, 
pH 8.0, 140 mM NaCl, 1% Triton X-100, 10% glycerol, 1 mM EGTA, 1.5 mM MgCl2,  1 
mM dithiothreitol, 1 mM phenylmethylsulphonyl fluoride) supplemented with a protease 
inhibitor cocktail (Millipore Sigma) and then briefly sonicated. For preparation of cell 
lysates, cultures were rinsed with PBS, lysed in ice-cold IP buffer (Li et al, 2012), briefly 
sonicated, centrifuged and resulting supernatants used for IP, pull-down assays and directly 
for western blot analysis. The protein concentration in all samples was determined using a kit 
(BioRad Laboratories, Hercules CA). For immunoblotting, samples in loading buffer were 
separated by sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-PAGE), and 
proteins transferred to polyvinylidene difluoride membranes. Following transfer, membranes 
were blocked for 60 min in TBS-Tw (20 mM Tris pH 7.4, 150 mM NaCl, and 0.2% Tween-
20) containing 5% skim milk powder and then incubated overnight at 4C with primary 
antibody in TBS-Tw containing 1% skim milk. After washing in TBS-Tw, blots were 
incubated with horse radish peroxidase-conjugated secondary antibodies and reactive bands 
revealed by chemiluminescence (Fisher Scientific).  
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Co-immunoprecipitation and pull-down assays 
Co-immunoprecipitation (co-IP) of proteins from brain extracts was conducted as we have 
previously described (Li et al., 2004a, 2012). In brief, clarified brain homogenates in IP 
buffer were precleared with protein-A agarose beads and centrifuged. Supernatants were 
incubated overnight at 4 °C with anti-LNX1 ab200, followed by 1 h incubation with protein-
A coated agarose beads. After centrifugation, beads were washed extensively with washing 
buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl and 0.5% NP-40) and then incubated at 60 
°C for 20 min in SDS-PAGE loading buffer containing 10% β-mercaptoethanol. Samples 
were taken for western blotting as described above. Control samples were taken through the 
IP procedure with exclusion of primary antibody. For IP of ubiquitinated Cx36-eCFP, cells 
co-transfected for 16-18 hrs with Cx36-eCFP, HA-ubiquitin and with either LNX2-FLAG, 
LNX2C51A-FLAG or FLAG-vector were lysed in radioimmunoprecipitation buffer (RIPA; 50 
mM Tris pH 8.0, 150 mM NaCl, 1.0% IGEPAL CA-630, 0.5% sodium deoxycholate; 
modified from Takahashi et al., 2009) containing 2% SDS, protease inhibitors and 10 mM N-
ethylmaleimide, and then briefly sonicated and clarified by centrifugation at 15,000 x g for 10 
min. In sample aliquots containing 200 μg total protein, the 2% SDS was brought down to 
0.1% SDS using diluent RIPA buffer that lacked SDS, and samples were then precleared with 
protein-G magnetic beads (Dynabeads, ThermoFisher) for 1 h at 4 °C. The precleared lysates 
were incubated overnight at 4 °C with either 2 μg of anti-eGFP or 2 μg of normal rabbit IgG 
(Santa Cruz) and then incubated for 1.5 h with 50 μl of protein-G magnetic beads. After 
extensive washing in RIPA buffer, beads were diluted with SDS-PAGE loading buffer 
supplemented with 10% β-mercaptoethanol and boiled for 10 min. Following separation of 
beads from IP material with magnetic force, IP material was electrophoresed by SDS-PAGE 
using 10% gels made using a TGX-Stain-Free FastCast Acrylamide kit (Bio-Rad), transferred 
to PVDF membranes using the semi-dry Trans-Blot-Turbo system according to 
manufacturer’s instructions (Bio-Rad) and imaged with a Chemidoc MP imaging system 
(Bio-Rad). Membranes were probed with antibodies using procedures described above. IP 
experiments showing accumulation of ubiquitinated Cx36-eCFP in the presence of LNX2 and 
reduced accumulation in presence of LNX2C51A-FLAG were repeated three times with similar 
results as shown in Figure 9A. Experiments showing effects of LNX2-FLAG or LNX2C51A-
FLAG on Cx35-eCFP detection or chloroquine and NH4Cl-mediated recovery of Cx36-eCFP 
detection in the presence of LNX2-FLAG were repeated three times with similar results as 
shown in Figure 10. 
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 For pull-down assays, a bacterially expressed GST-LNX1 fusion protein plasmid was 
used to investigate molecular interaction between Cx36 and LNX1. Fusion protein was 
prepared, and pull-downs using this fusion protein and HeLa-Cx36 cell lysates were 
performed as we have previously described (Li et al., 2004a, 2012). To characterize 
interactions between Cx36 and the PDZ domains of LNX1 and LNX2, bacterial expression 
plasmids containing the separate His-tagged PDZ domains of LNX1 or LNX2 in the pET30A 
vector were utilized (a gift from Dr. R. Hall, Emory University School of Medicine, Atlanta 
GA, USA; Fam et al., 2005). Plasmids were introduced into competent e-coli BL21 (DE3) 
cells and fusion protein expression was induced with 1 mM isopropyl-β-d-
thiogalactopyranoside. Following bacterial cell lysis and clarification of the extract, His-
tagged fusion proteins were purified from the supernatant using Ni-NTA resins according to 
manufacturer’s instructions (Novagen, Madison, WI, USA) and used in pull-down assays as 
described elsewhere (Li et al., 2012). Briefly, nickel beads linked to fusion proteins 
containing His-tagged PDZ domains 1-4 of LNX1 or PDZ domains 1,2 and 4 of LNX2 were 
incubated overnight with lysates of HeLa or N2A cells transfected with plasmid encoding 
either Cx36 or trCx36 lacking its 4 amino acid terminal PDZ ligand. The beads were washed 
in PBS buffer containing 1% Triton X-100 and proteins were eluted from beads by incubation 
for 15 min at 60 oC with SDS-PAGE sample buffer. The resulting pull-down samples were 
then analyzed by western blotting. Pull down assays as described above for the PDZ domains 
of LNX1 and LNX2 were repeated three times with similar results as shown in Figures 6 and 
7. 
To confirm loss of LNX1 proteins in gene targeted mice, tissue homogenates from adult 
LNX1 null and wild-type controls were taken for immunoblotting and immunoprecipitation. 
Tissues were collected and homogenized in radioimmunoprecipitation buffer. Total protein 
concentration of homogenates was determined, 50 μg of protein was separated by SDS-
PAGE, immunoblotted as described above, and blots were probed with anti-LNX1 ab8 
antibody. Immunoprecipitation of LNX1 from tissue homogenates was conducted using anti-
LNX1 ab365 antibody or normal rabbit IgG. Immunoprecipitates were immunoblotted and 
probed with anti-LNX1 ab8. 
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Results  
Immunofluorescence localization of Cx36, LNX1 and LNX2 in brain 
Immunofluorescence labelling of LNX1 in combination with labelling for Cx36 was 
examined in the inferior olive of mouse and rat, and in the retinal inner plexiform layer of 
mouse, two areas where neuronal gap junctions containing Cx36 are highly concentrated (Li 
et al., 2004a; Kamasawa et al., 2006). As previously described, immunolabelling for Cx36 
appears exclusively punctate throughout the CNS, and ultrastructural studies involving 
freeze-fracture replica immunogold labelling (FRIL) have established its localization at 
neuronal gap junctions (Nagy et al., 2004; Rash et al., 2007a,b). Because intracellular Cx36 
in neurons in vivo remains undetectable with currently available anti-Cx36 antibodies for 
reasons as yet undetermined (Nagy et al., 2013; Bautista & Nagy, 2014; Rubio & Nagy, 
2015), immunofluorescence localization of this connexin is considered to reveal sites in vivo 
at which it is contained in gap junctions (Nagy et al., 2017, 2018). The typical punctate 
appearance of Cx36 labelling at neuronal gap junctions is shown in the mouse inferior olive 
in Figure 1A1, where we refer to this labelling as Cx36-puncta. Immunofluorescence 
labelling of LNX1 was also largely punctate in this structure, hence referred to as LNX1-
puncta, and had a distribution very similar to that of Cx36 (Fig. 1A2). Double 
immunofluorescence labelling of Cx36 in combination with labelling of LNX1 showed that 
in overlay images many Cx36-puncta were co-localized with LNX1-puncta (Fig. 1A3), 
indicating localization of LNX1 to neuronal gap junctions. Conversely, not all LNX1-puncta 
were associated with labelling for Cx36. Where co-localization occurred, labelling for LNX1 
was often confined entirely within an areas occupied by individual Cx36-puncta, and 
sometimes LNX1 was curiously confined to small subregions of those puncta.     
 A control for specificity of LNX1 detection and LNX1/Cx36 co-localization was 
provided by the use of two LNX1 antibodies directed against different, non-overlapping 
sequences within this protein. Labelling patterns obtained in the inferior olive of mouse with 
anti-LNX1 ab247 (Fig. 1B) was similar to that obtained with anti-LNX1 ab200 (Fig. 1C), and 
both gave similar co- localization with Cx36 (Fig. 1B and 1C). Examination of labelling in 
genetically ablated LNX1 deficient mice (LNX1 KO mice) was used as a further control for 
localization of LNX1 at Cx36-containing gap junctions. In the inferior olive of these KO 
mice, labelling with both anti-LNX1 ab247 and ab200 was totally absent at Cx36-puncta 
(Fig. 1D and 1E). However, both antibodies produced residual punctate labelling, which 
appear to represent cross reaction with another as yet unidentified protein, perhaps a closely 
related member of the family of LNX proteins (Katoh & Katoh, 2004). Counts of 
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immunopositive puncta in 10-14 fields double- labelled for Cx36 and LNX1 revealed that 50 
± 3.2% and 42 ± 3.2% (mean ± s.e.m. of the number of field examined) of Cx36-puncta were 
co-localized with LNX1-puncta labelled with anti-LNX1 ab200 and ab247, respectively, in 
sections of inferior olive from wild-type mice, while this was reduced to 2 ± 1.2% and 1 ± 0.4 
Cx36-puncta co-localization with LNX1-puncta using these antibodies for labelling in 
sections from LNX1 KO mice. Immunofluorescence labelling of Cx36 in combination with 
immunolabelling of LNX1 in the inner plexiform layer of mouse retina (Fig. 2A) and in the 
inferior olive of rat (Fig. 2B) gave similar results as in the inferior olive of mouse. In both of 
these CNS regions, many Cx36-puncta displayed co- localization with LNX1 and, conversely, 
some LNX1-puncta in both areas showed an absence of association with Cx36-puncta. 
 We next examined double immunofluorescence labelling for Cx36 in conjunction with 
labelling for LNX2 in the inferior olive of mouse. Throughout this structure, where Cx36-
puncta are abundantly found (Fig. 3A1), labelling of LNX2 had a closely matching 
distribution, and was also evident exclusively as immunoreactive puncta (Fig. 3A2), but the 
density of LNX2-puncta was somewhat less than that of Cx36-puncta (Fig. 3A3). Consistent 
with this observation and in contrast to results concerning LNX1, it appeared that the vast 
majority of LNX2-puncta were co- localized with Cx36 but, conversely, not all Cx36-puncta 
were associated with labelling for LNX2 (Fig. 3B and 3C). The degree of co-localization of 
Cx36 with LNX2 at individual puncta exhibited a variety of patterns. Where co- localization 
occurred, labelling for LNX2 either entirely encompassed Cx36-puncta and extended beyond 
the area occupied by Cx36-puncta, or was confined entirely within Cx36-puncta, occupying 
large to very small spatial subregions of the area circumscribed by Cx36-puncta (Fig. 3B, and 
C). Also frequently observed was partial overlap of labelling for Cx36 and LNX2 at 
individual puncta (Fig. 3B,C).  
 
Immuoblotting and Cx36 co-IP with LNX1 
Recognition of LNX1 with the rabbit polyclonal anti-LNX1 ab200 antibody we generated 
was demonstrated by immunoblotting of HeLa cell lysates derived from transiently 
transfected cells expressing LNX1p70 or LNX1p80-FLAG. In these lysates, bands were 
detected migrating at ~70 kDa and ~80 kDa (Fig. 4A, lanes 1 and 2), which corresponded to 
apparent molecular weights of LNX1p70 and LNX1p80-FLAG, respectively. These bands 
were absent in non-transfected wild-type (WT) cells (HeLa-WT; Fig. 4A, lane 3). Probing the 
same lysates with anti-FLAG revealed detection of the LNX1p80-FLAG, corresponding to 
this LNX1 isoform recognized by anti-LNX1, but not the non-FLAG tagged LNX1p70 
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isoform (Fig. 4A, lanes 4 and 5, respectively). Comparison of results with anti-LNX1 ab200 
vs. ab247 after immunoblotting of these same lysates is shown in Fig. 4B, which indicated 
that each of these antibodies have the capacity to detect both the full- length isoform 
LNX1p80 and the shorter isoform LNX1p70. Immunoblotting of LNX1 and LNX2 in 
homogenates of brain is not shown due to difficulties in detection of these LNX isoforms in 
brain extracts, as also reported by others (Lenihan et al., 2017b).  
 The molecular association of LNX1 with Cx36 was initially examined by co-IP 
procedures. Homogenates of mouse brain taken for IP with anti-LNX1 showed detection of 
Cx36 in IP material probed with anti-Cx36 (Fig. 4C, lane 3). The migration profile of the 
band detected in the IP material corresponded to that of Cx36 in lysates of HeLa cells stably 
expressing Cx36 (HeLa-Cx36) (Fig. 4C, lane 2), and this band was absent after IP with 
omission of anti-LNX1 (Fig. 4C, lane 4). Specificity of the band identified as Cx36 is 
indicated by lack of its detection in a control lane loaded with lysate from non-transfected 
HeLa-WT cells (Fig. 4, lane 1). In an initial pull-down experiment, we examined the 
interaction of Cx36 with bacterially expressed LNX1-GST fusion protein. Immunoblots of 
lysates of HeLa-Cx36 cells taken for pull-down with LNX1-GST and probed with anti-Cx36 
showed detection of a band (Fig. 4D, lane 2) that co-migrated with Cx36 seen in input lysate 
from HeLa-Cx36 cells (Fig. 4D, lane 1). Further effort to examine interaction of LNX 
proteins with Cx36 was focused not using brain tissue, but rather transfection of cells in 
culture. 
 
Immunoblotting of tissues from LNX1 null mice 
To confirm that LNX1 gene targeted mice were deficient for LNX1, tissue homogenates from 
these mice and their wild-type counterparts were taken for immunoblotting and 
immunoprecipitation using LNX1 antibodies raised against distinct regions of LNX1. As 
expected, anti-LNX1 ab8 antibody detected LNX1p80 in wild-type tissues, but not in tissues 
from LNX1 KO mice (Fig. 5A). Lack of detection of LNX1p80 in lanes loaded with 
homogenate from wild-type small intestine is likely attributable to an insufficient amount of 
protein loading as indicated by only a small fraction of actin detected in lanes loaded with 
this tissue as compared to lanes loaded with other samples. Nonetheless, results for kidney, 
liver, cecum and colon provided evidence that LNX1 p80 protein was present in wild-type 
tissues and absent in these tissues of LNX1 KO mice. In blots of material obtained after IP 
with anti-LNX1 ab365 and probed with anti-LNX1 ab8 (Fig. 5B), the brain-specific 
LNX1p70 isoform was detected in IP material from wild-type brain, while the p80 isoform 
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was not detected (Fig. 5B, lane 1). In contrast, IP material from peripheral tissue 
homogenates (heart, colon and kidney) showed the presence of the p80 isoform and absence 
of the p70 isoform (Fig. 5B, lanes 3, 5, 7). After IP from tissues of LNX1 KO mice, these 
was an absence of LNX1 detection (Fig. 5B, lanes 2, 4, 6, 8), confirming ablation of the 
LNX1 in these mice and providing confidence in the identity of LNX1 bands seen in blots of 
IP material from wild-type tissues. Positive control IPs showed detection of LNX1p70 (Fig. 
5B, lane 9) and LNX1p80 (Fig. 5B, lane 10) in IP material from lysates of LNX1p70- or 
LNX1p80-transfected HEK293T cells, respectively. A band migrating slightly faster than the 
LNX1p70 isoform seen only in IP material from wild-type brain, and which like the p70 
isoform was absent after IP from brain of LNX1 KO mice, may represent the p62 isoform of 
LNX1 that was reported to be uniquely expressed in brain (Lenihan et al., 2014). Intense 
bands running at an even lower molecular weight that were detected in wild-type colon and 
kidney (Fig. 5, lanes 5 and 7, respectively) and that were absent in LNX1 KO mice may 
represent degradation products of LNX1. 
 
Pull-down of Cx36 with PDZ domains of LNX1 and LNX2 
To more comprehensively examine molecular interactions between LNX proteins and Cx36 
in vitro, bacterial fusion proteins expressed from recombinant plasmids containing His-
tagged PDZ domains of LNX1 and LNX2 were used for pull-down assays. Pull-downs 
involved incubation of the His-PDZ domains with lysates of HeLa or N2A cells that had been 
transfected with either full- length Cx36 or truncated Cx36 (trCx36) lacking the C-terminal 
four amino acids that constitute its PDZ ligand. Immunoblots loaded with positive control 
input lysates and probed with anti-Cx36 showed detection of Cx36 and trCx36 in material 
used for pull-downs with LNX1 PDZ domains (Fig. 6A, lane 1; and 6C, lanes 2,3) or for pull-
downs with LNX2 PDZ domains (Fig. 7, lanes 1,5). The Cx36 band was absent in HeLa-WT 
cells (Fig. 6A, lane 2 and 6C, lane 1) as well as in N2A-WT cells (not shown). Full- length 
Cx36 was detected after pull-down with the second PDZ domain of both LNX1 (Fig. 6A, 
lane 4) and LNX2 (Fig. 7A, lane 3), but was absent in pull-downs using the PDZ1, PDZ3 and 
PDZ4 domains of LNX1 (Fig, 6A, lanes 3, 5 and 6, respectively) or the PDZ1 and PDZ4 
domains of LNX2 (Fig. 7A, lanes 2 and 4, respectively). This molecular interaction between 
Cx36 and the PDZ2 domains of the two LNX proteins was abrogated when pull-downs were 
conducted with trCx36 and either the PDZ2 domain of LNX1 (Fig. 6C, lane 5) or the PDZ2 
domain of LNX2 (Fig. 7A, lane 6), indicating requirement of the Cx36 PDZ ligand for 
interaction of Cx36 with LNX1 or LNX2. Blots probed for pull-down material were stripped 
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and re-probed with monoclonal anti-His (Fig. 6B, lanes 7-12; Fig. 6D, lanes 6 and 7, which 
corresponded to lanes 4 and 5 in Fig. 6C; and Fig. 7B, lanes 7-12). These blots probed with 
anti-His showed approximately equivalent amounts of His-PDZ domain fusion proteins were 
used in the pull-down assays. 
 
Localization of Cx36-eCFP, LNX1 and LNX2 in co- transfected cells 
To examine the effect of LNX expression on Cx36 localization in cultured cells, N2A cells 
were co-transfected with Cx36-eCFP (Fig. 8) and with either LNX1p80-FLAG, LNX1p70 
that lacks E3 ligase activity, LNX2-FLAG or with the functional mutant form of LNX2 
(LNX2C51A-FLAG) that has a mutated zinc coordination RING domain essential for ligase 
activity. When transfected alone into cells, the intrinsic fluorescence of Cx36-eCFP was 
typically distributed at both intercellular gap junctions and to punctate intracellular structures 
(Fig. 8A). Cells transfected with Cx36-eCFP (Fig. 8B1) and immunolabelled with anti-Cx36 
(Fig. 8B2), showed co-localization of eCFP fluorescence and Cx36 immunofluorescence (Fig 
8B3), providing confidence in specificity of Cx36 detection in cultured cells. Cells co-
transfected with Cx36-eCFP and LNX1p70 (Fig. 8C1) and simultaneously probed with anti-
Cx36 (Fig. 8C2) and anti-LNX1 (Fig. 8C3) displayed co- localization of eCFP fluorescence, 
immunolabelling of Cx36 and immunolabelling of LNX1p70 at large gap junctions located at 
intercellular contacts and at intracellular punctate structures (Fig. 8C4). In contrast, cells co-
transfected with Cx36-eCFP (Fig. 8D1) and LNX1p80-FLAG (Fig. 8D3), and probed with 
anti-Cx36 (Fig. 8D2) showed a loss of signals for eCFP and Cx36 at cell-cell contacts, with 
retention of only a fractional amount of intracellular Cx36-eCFP fluorescence. Cells 
expressing LNX1p80-FLAG (Fig. 8E) taken for double- labelling with anti-FLAG (Fig. 8E1) 
and anti-LNX1 (Fig. 8E2) showed a similar distribution of intracellular immunofluorescence 
for the FLAG tag and LNX1, indicating fidelity for LNX1p80-FLAG detection and 
confirming the diffuse nature of LNX1p80 immunoreactivity in these cells.  
 In cells expressing Cx36-eCFP (Fig. 8F1) and LNX2-FLAG (Fig. 8F2), and probed with 
anti-FLAG, there was an absence of Cx36-eCFP at cell-cell contacts suggesting lack of gap 
junctions, while intracellular Cx36-eCFP was retained, but at diminished levels. To determine 
if absence of Cx36-eCFP-containing gap junctions was dependent on the E3 ligase activity of 
LNX2, N2A cells were co-transfected with Cx36-eCFP and with mutant LNX2C51A-FLAG. 
In these cells, Cx36-eCFP fluorescence was maintained at cell-cell contacts presumably 
reflecting gap junctions, and appeared at intense levels intracellularly (Fig. 8G1), and FLAG 
immunoreactivity for LNX2C51A-FLAG was seen co- localized with eCFP (Fig. 8G2).  
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LNX2 mediated ubiquitination of Cx36 
To determine if Cx36 is targeted for ubiquitination by LNX2 and if so whether ubiquitination 
of Cx36-eCFP by LNX2 required a functional RING domain of LNX2, lysates of cells 
expressing Cx36-eCFP and HA-ubiquitin together with either LNX2-FLAG, LNX2C51A-
FLAG or FLAG vector were taken for IP of Cx36-eCFP, immunoblotted and probed with 
anti-HA for detection of HA-ubiquitin conjugated to Cx36-eCFP in the IP material (Fig. 9).     
The results indicated increased HA-ubiquitinated material present in IP material gathered 
from cells expressing LNX2-FLAG (Fig. 9A, lane 2) vs. those expressing the empty FLAG-
vector (Fig. 9A, lane 1), and the increase was not seen in Cx36-eCFP IP material from cells 
expressing the LNX2C51A-FLAG mutant that lacks a functional RING domain (Fig. 9A, lane 
3). These results suggest that Cx36-eCFP is subject to ubiquitination mediated by LNX2, 
which is consistent with findings by others in studies of various targets of LNX E3 ligases, 
including claudins, KIF7 (kinesin- like protein), ERC2 (ERC protein2) and SRGAP2 (SLIT-
ROBO Rho GTPase-activating protein 2), where ubiquitination by LNX was shown to 
require a functional RING domain (Lenihan et al., 2014; Takahashi et al., 2009). The lack of 
HA detection in control IPs  conducted with normal rabbit IgG and lysates of the same 
LNX2-FLAG transfected cells used in lane 2 (Fig. 9A, lane 4) indicated that HA detection in 
IPs performed with anti-eGFP antibody was not due to non-specific binding of HA-
ubiquitinated proteins to Protein G conjugated magnetic beads or to IgG. This latter 
observation suggests that our detection of baseline levels of HA-ubiquitinated Cx36-eCFP in 
IPs of FLAG-vector co-transfected cells was potentially due to either a small degree of non-
specific IP of proteins with anti-eGFP or to the activity of an as yet unidentified endogenous 
E3 ubiquitin ligase on Cx36-eCFP in N2A cells. This latter possibility is consistent with 
observations concerning other proteins that are acted upon by multiple E3 ubiquitin ligases,  
including  p53 and Cx43 (Chen et al., 2012; Fykerud et al., 2012; Satija et al., 2013; Basheer 
et al., 2015 ). However, we cannot at present exclude the possibility that LNX2 interacts with 
and mediates the ubiquitination of additional proteins that directly or indirectly associate with 
Cx36 and are localized at neuronal gap junctions.  
 
Rescue of Cx36 from degradation by LNX2 
We next determined if lysosomal inhibition with chloroquine or ammonium chloride could 
rescue the loss of Cx36-eCFP in cells overexpressing LNX2. This was examined by 
immunoblotting of lysates from cells co-transfected with Cx36-eCFP (Fig. 10A, lanes 1 to 7) 
and either LNX2-FLAG, LNX2C51A-FLAG or empty FLAG vector, followed by probing of 
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immunoblots with anti-Cx36 ab51-6300. In cells transfected with Cx36-eCFP and co-
transfected with FLAG-vector, anti-Cx36 recognized a band migrating ~60 kDa, close to the 
calculated molecular weight of Cx36-eCFP (Fig. 10A, lane 1), which was absent in cells 
transfected with FLAG-vector only (Fig. 10A, lane 8). The Cx36-eCFP band was only 
weakly detected in cells expressing LNX2-FLAG (Fig. 10A, lane 2), whereas the robust 
expression of Cx36-eCFP was retained in cells expressing the LNX2C51A mutant (Fig. 10A, 
lane 3). When cells expressing Cx36-eCFP and LNX2 were treated with chloroquine (Fig. 
10A, lanes 4-6; 10, 50, 100 mM, respectively) or 25 mM ammonium chloride (Fig. 10A, lane 
7), the intense band for Cx36-eCFP was recovered. After stripping, the immunoblot shown in 
Figure 10A was reprobed with anti-FLAG, which showed roughly equal abundance of 
LNX2-FLAG in all lanes loaded with lysates from cells co-transfected with Cx36-eCFP and 
LNX2-FLAG (Fig. 10B, lanes 10, 12-15), as well as in lysate from cells co-transfected with 
Cx36-eCFP and LNX2C51A-FLAG (Fig. 10B, lane 11), and its absence in cells transfected 
with Cx36-eCFP and FLAG-vector (Fig. 10B, lane 9), or FLAG-vector only (Fig. 10B, lane 
16). These results indicate that the ultimate fate of Cx36-eCFP in cells overexpressing LNX2-
FLAG was its targeting to the lysosomal compartment for degradation.  
 
Discussion 
Localization of LNX1 and LNX2 in vivo 
The present results add Cx36 to the list of proteins that interact with LNX1 and/or LNX2 
(LNX1/2) and that may serve as targets for ubiquitination by one or the other of these E3 
ubiquitin ligases. The cellular distribution and subcellular localization of LNX1/2 proteins in 
the CNS has not as yet been subject to comprehensive documentation, owing perhaps to the ir 
apparently low levels of expression in neural tissue (Lenihan et al., 2014), and difficulties in 
their detection with currently available anti-LNX antibodies. LNX1 and LNX2 mRNAs have, 
however, been localized by in situ hybridization primarily in neurons in brain (Rice et al., 
2001; Lenihan et al, 2014), and the present immunofluroescence results indicate that at least 
some of those neurons correspond to neuronal populations that express Cx36. The 
localization of LNX1/2 specifically at sites of Cx36-puncta in the brain regions examined 
indicates with reasonable certainty that these E3 ligases in part reside at Cx36-containing gap 
junctions that form electrical synapses, because (as noted earlier) immunofluorescence 
labelling of Cx36 with the antibodies and immunolabelling protocols used here appears to be 
restricted exclusively to cellular sites at which this connexin forms gap junctions (Rash et al., 
2001; Nagy et al., 2004; Rash et al., 2007a,b; Nagy et al., 2017, 2018). Although anti-LNX1 
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detects both p70 and p80 as shown here in transfected cells, it likely recognized LNX1p70 at 
these junctions given the absence of LNX1p80 expression in brain (Rice et al., 2001; Lenihan 
et al., 2014). We examined LNX1/2 association with Cx36 in only a few limited brain 
regions that harbor the highest density of Cx36-containing gap junctions, namely the retina 
and inferior olivary nucleus. However, these junctions are known to be widely distributed in 
brain and spinal cord (Condorelli et al., 2000; Bautista et al., 2014; Nagy et al., 2018). Thus, 
it remains to be determined whether LNX1/2 proteins are similarly associated with Cx36 in 
other regions of the CNS.  
 We have previously reported the immunofluorescence localization of several other 
proteins at Cx36-containing gap junctions in adult rat and mouse brain, including ZO-1, AF6 
(aka, afadin), cingulin and MUPP1 (Li et al., 2004a, 2012; Lynn et al., 2012). Labelling for 
some of these proteins (e.g., ZO-1, cingulin) often showed total overlap of labelling with 
Cx36 at individual Cx36-puncta. Here, a remarkable heterogeneity was seen in the degree of 
overlap between labelling for LNX proteins and Cx36 at Cx36-puncta. In cases where 
labelling for LNX1/2 extended beyond the bounds of Cx36-puncta, LNX1/2 outside of, but 
contiguous with, these puncta could be associated with plasma membrane structures 
immediately adjacent to Cx36-puncta (i.e., adherens junctions, Nagy & Lynn, 2018). Indeed, 
protein components of other types of cell-cell junctions, including E-cadherin at adherens 
junctions and claudin-1 plus occludin at tight junctions, are targets for ubiquitination by 
RING- and Hect-type E3 ubiquitin ligases (Fujita et al., 2002; Traweger et al., 2002; 
Takahashi et al., 2009), raising the possibility that one or more of the many components of 
adherens junctions that flank Cx36-containng gap junctions may represent binding partners of 
LNX1/2. Labelling of LNX1/2 entirely confined within and occupying variable tiny to large 
portions of Cx36-puncta suggest that actions of LNX1/2 may be operative within subdmains 
of Cx36-containing gap junctions. If LNX1/2 contributes to processes governing turnover of 
Cx36, then these subdomains may correspond to sites within Cx36-containing gap junction 
plaques where a portion of this connexin may undergo removal by internalization, as has 
been reported to occur at gap junctions composed of other connexins (Lauf et al., 2002; 
Gaietta et al., 2002; Laird, 2006; Flores et al., 2012). It is noteworthy in this context that 
ultrastructural studies have demonstrated endocytic annular profiles to be associated also with 
subdomains of Cx36-containing gap junctions between neurons in mammalian brain, 
specifically parvalbumin expressing neurons in the striatum, and these profiles were 
interpreted to represent portions of gap junctions undergoing internalization (Fukuda, 2009), 
which interestingly may correspond to subdomains of Cx36-puncta found to harbour 
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LNX1/2.  In view of these considerations, it may be of interest to explore the characteristics 
of Cx36 turnover, morphological features and deployment of Cx36-containing gap junctions 
in the CNS of LNX1/2 KO mice.  
 
Connexin E3 ubiquitin ligase interactions  
Studies on the turnover, recycling and degradation of gap junctions have focused mainly on 
Cx43, which undergoes processing by both the lysosomal and proteasomal pathways (Leithe, 
2016), with Cx43 degradation regulated by both its phosphorylation and by ubiquitination via 
the E3 ubiquitin ligase Nedd4, which co- localized with Cx43 at gap junctions (Leykauf et al., 
2006; Leithe & Rivedal, 2004; Leithe et al., 2006; Leithe & Rivedal, 2007). These findings 
suggested that Cx43 was ubiquitinated at gap junctions within the plasma membrane, which 
signalled Cx43 for ultimate proteasomal degradation. Subsequently, Cx43 was found to 
undergo ubiquitination by other E3 ubiquitin ligases (Chen et al., 2012; Fykerud et al., 2012; 
Basheer et al., 2015), and additional connexins were reported to be ubiquitinated, including 
connexin26, connexin32 and connexin40 (Leithe, 2016). We now add Cx36 to this list, which 
expands the growing number of substrates and/or binding partners of LNX1/2 proteins that 
were identified by biochemical or proteomic methods and by strategies that combined 
biochemical approaches with bioinformatic analysis (Song et al., 2006; Wolting et al., 2011; 
Guo et al., 2012). 
 Our finding that the classical C-terminal four amino acid PDZ ligand of Cx36 (i.e., 
SAYV), which is required for interaction of Cx36 with PDZ domains in AF6, MUPP1 and of 
ZO-1 (Li et al., 2004a, 2009, 2012), mediates Cx36 association with the PDZ2 domains of 
both LNX1 and LNX2 is consistent with the highly homologous sequence of these two LNX 
proteins, particularly in regions that define their substrate specificity (Rice et al., 2001; Flynn 
et al., 2011). Based on our results from transfected cells in culture, it is likely that association 
of LNX1/2 with electrical synapses in brain arises by virtue of Cx36 PDZ ligand interaction 
with the PDZ2 domains in LNX1/2. This was supported by co- localization of Cx36-
containing gap junctions with both the catalytically inactive LNX1p70 isoform and LNX2 
isoform bearing an E3-ubiquitin ligase loss of function mutation in transfected cells. These 
results suggested LNX1/2 targeting to Cx36 at the plasma membrane, similar to such 
targeting of the E3 ubiquitin ligase Nedd4 to gap junctions composed of Cx43  ((Leithe, 
2016). Co-localization of Cx36 with LNX1p80 or LNX2 in transfected cells was not 
observed due to the loss of Cx36 at cell-cell contacts, which was interpreted to indicate a 
potential ubiquitin-related mechanism for degradation of Cx36 by these E3 ligase-competent 
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isoforms of LNX1/2, as supported by the observed retention of Cx36-containing gap 
junctions in cells expressing the LNX2 loss of function mutant. Consistent with this idea was 
that ubiquitination of Cx36-eCFP in the presence of LNX2 was not observed in cells 
transfected with the LNX2C51A mutant. Further, the observed loss of Cx36-eCFP in cells 
expressing LNX2 was not seen in cells expressing mutant LNX2 lacking a functional RING 
domain. In addition, the loss of Cx36-eCFP detection seen in the presence of LNX2 was 
abrogated by treatment of LNX2-expressing cells with inhibitors of lysosomal degradation, 
suggesting that one mechanism for ubiquitinated Cx36 degradation is via the lysosomal 
pathway, similar to processing of Cx43 after its Nedd1-mediated ubiquitination or to the 
ubiquitination and degradation of claudins in MDCK cells overexpressing LNX1, and 
recovery of claudin detection in these cells by treatment with lysosome inhibitors (Leithe, 
2016; Takahashi et al., 2009).  
 Results concerning LNX1p80, although consistent with those involving LNX2, are 
perhaps less physiologically relevant given the absence of LNX1p80 expression in adult brain 
as seen here and reported by others (Rice et al., 2001; Lenihan et al., 2014). In this regard, it 
is noteworthy that both LNX1 and LNX2 contain, in addition to four unique PDZ domains, 
classical C-terminal PDZ ligand motifs, and LNX1 was shown to interact with LNX2 and has 
a similar cell-type expression pattern and regional distribution as LNX2 (Rice et al., 2001; 
Lenihan et al., 2014). It has been suggested that the observed self-binding of the PDZ1 
domains of LNX1/2 with their own C-terminal PDZ ligands may serve to inhibit interaction 
with target PDZ ligands, providing a mechanism for self-regulating their actions on target 
proteins (Rice et al., 2001). Our results showing the presence of both LNX1/2 at Cx36-
containing neuronal gap junctions, together with our findings and reports that only LNX1 
protein isoforms that lack E3 ligase activity are expressed in brain (Rice et al., 2001; Lenihan 
et al., 2014), suggest that LNX1 at electrical synapses may confer stability on these synapses 
via PDZ-mediated regulatory interactions with LNX2 that inhibit the E3 ligase activity of 
LNX2 on Cx36. Alternatively, the association of E3 ligase- incompetant LNX1p70 with Cx36 
may moderate, in a competitive manner, the availability of Cx36 for interaction with ligase-
competant LNX2.  
 Sequence analyses have revealed that the LNX1/2 genes are ancestrally related to the 
multi-PDZ domain protein1 (MUPP1) that contains thirteen PDZ domains, the last four (PDZ 
10-13) of which share similar splice junctions and primary sequence homology with PDZ1-4 
domains of LNX1/2 (Flynn et al., 2011). Computed potential PDZ interactions (Hui et al., 
2010) revealed that almost all proteins predicted to interact with the PDZ1 or PDZ2 domains 
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of LNX1/2 do interact with either PDZ10 or PDZ11 of MUPP1 (Flynn et al., 2011). It was 
shown empirically that interactors with MUPP1 PDZ10-13, including the synaptic proteins 
SynGap1 (synaptic GTPase activating protein) and HTR2C (Serotonin receptor 2C subunit), 
also interacted with the PDZ1 and 2 domains of LNX1/2 (Flynn et al., 2011). These 
predictive/empirical findings are supported by our previous report on the interaction of Cx36 
with the 10th PDZ domain of MUPP1 (Li et al., 2012) taken together with the present 
demonstration of Cx36 interaction with the PDZ2 domains of LNX1/2.  
 
Conclusions 
Mechanisms underlying the dynamic nature and reported plasticity of electrical synapses 
formed by Cx36-containing neuronal gap junctions may be diverse, and the biochemical 
correlates of these mechanisms may be commensurate with an equally diverse composition of 
structural and regulatory proteins associated with these synapses. Thus, in addition to various 
previously reported cellular processes that could potentially influence the efficacy of 
electrical synaptic transmission (Pereda et al, 2013; Pereda, 2014; Nagy et al., 2018), the 
actions of LNX1/2 at electrical synapses composed of Cx36 could in part provide the basis 
for the steady-state turnover of Cx36 at gap junctions. These LNX isoforms may also govern 
rapid, moment-to-moment trafficking of Cx36-containing channels at these junctions, thereby 
regulating the availability of functional channels for mediation of electrical coupling.  
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Figure legends  
 
Fig. 1. Immunofluorescence co-localization of LNX1 with Cx36 in the inferior olive of adult 
mouse. The series of three images (1-3) for each of A to E show the same field double-
labelled for Cx36 (red) and LNX1 (green), with image merge where red/green overlap 
appears yellow. (A) Low magnification showing the punctate appearance and relative density 
of immunolabelling for Cx36 (A1) and LNX1 (A2), and a high degree of co- localization 
(A3). (B,C) Higher magnifications showing labelling of Cx36 in combination with anti-
LNX1 ab247 (B) or anti-LNX1 ab200 (C). Most Cx36-puncta are co- localized with LNX1 
(arrows), but not all LNX1-puncta are associated with Cx36-puncta (arrowheads). (D,E) 
labelling of Cx36 with anti-LNX1 ab247 (D) or anti-LNX1 ab200 (E) in the inferior olive of 
LNX1 KO mice. Both anti-LNX1 antibodies produce residual punctate labelling (D,E, 
arrowheads), but Cx36-puncta are totally devoid of labelling for LNX1, as seen in overlays 
(D3,E3, arrows).  
 
Fig. 2. Immunofluorescence co- localization of LNX1 with Cx36 in the retina of adult mouse 
and the inferior olive of adult rat. (A) Inner plexiform layer of mouse retina, showing Cx36-
puncta (A1, arrows) and in the same field immunolabelling with anti-LNX1 ab200 (A2, 
arrows), with overlay showing nearly all Cx36-puncta co-localized with LNX1 (A3, arrows). 
(B) Rat inferior olive showing Cx36-puncta (B1, arrows) and in the same field labelling with 
anti-LNX1 ab247 (B2, arrows), with overlay showing all Cx36-puncta co- localized with 
LNX1 (B3, arrows), as also shown at higher magnification in inset. In both mouse retina and 
rat IO, not all labelling for LNX1 is associated with Cx36.  
 
Fig. 3. Immunofluorescence co-localization of LNX2 with Cx36 in the inferior olive of adult 
mouse. (A) Low magnification showing punctate appearance of labelling for both Cx36 (A1, 
arrows) and LNX2 (A2, arrows), with substantial co- localization of puncta (A3, arrows). 
(B,C) Laser scanning confocal images of double labelling for Cx36 and LNX2 shown in 
overlay. At sites of Cx36 co-localization with LNX2, Cx36-puncta appear either within the 
confines of labelling for LNX2 (B, arrows) or display only partial overlap with LNX2-puncta 
(C, arrowheads). Some Cx36-puncta display only a very small portion of their area occupied 
by labelling for LNX2 (C, inset).  
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved.  
Fig 4. Immunoblots showing detection of LNX1p70 and LNX1p80 in transiently transfected 
HeLa cells, detection of Cx36 after IP of LNX1 from brain, and pull-down of Cx36 with 
GST-LNX1. (A) Blots of lysates from HeLa cells transiently transfected with LNX1p80-
FLAG or LNX1-p70, as indicated, and probed with anti-LNX1 (lanes 1-3) or anti-FLAG 
(lanes 4, 5), showing detection of LNX1p80 isoform migrating at ~80 kDa (lane 1) and the 
LNX1p70 isoform migrating at ~70 kDa (lane 2), and absence of these bands in HeLa-WT 
cells (lane 3). Lanes probed with anti-FLAG show detection of LNX1p80-FLAG (lane 4) and 
lack of detection of untagged LNX1p70 (lane 5). (B) Blots of lysates from HeLa cells 
transiently transfected with LNX1p80-FLAG or LNX1-p70, as indicated, and probed with 
anti-LNX1 ab247 (lanes 1, 2) or ab200 (lanes 3, 4), showing detection of both LNX1p80 and 
p70 isoform with each of the antibodies. (C) Blot probed with anti-Cx36 showing detection 
of Cx36 (lane 3) in material immunoprecipitated from mouse brain with anti-LNX1. Controls 
show a corresponding Cx36 band from lysate of HeLa-Cx36 cells (lane 2) and absence of this 
band in lysate of HeLa-WT (lane 1) or in immunoprecipitate from brain after antibody 
omission (lane 4). (D) Pull-down of Cx36 from HeLa-Cx36 cells with full- length GST-
tagged LNX1, showing a blot probed with anti-Cx36 and detection of a Cx36 band in pull-
down material (lane 2) corresponding to a band detected in lysate from HeLa-Cx36 cells. 
 
Fig. 5. Confirmation of LNX1 detection in tissues from wild-type mice and its absence in 
LNX1 KO mice. LNX1 protein expression and immunoprecipitation of LNX1 isoforms in 
tissues from wild type mice and absence of LNX1 protein in tissues from LNX1 gene ablated 
mice. (A) Total protein homogenates from adult wild-type (WT) and LNX1 knockout (KO) 
mouse tissues were immunoblotted with the anti-LNX1 ab8. LNX1p80 was detected in lanes 
loaded with proteins from wild-type kidney (lane 2), liver (lane 4), cecum (lane 8) and colon 
(lane 10), but not in adjacent lanes loaded with proteins of these tissues taken from LNX1 
KO mice (lanes 3, 5, 9, 11), showing lack of LNX1 expression in LNX1 KO mice. A positive 
control lane was loaded with protein lysate from LNX1p80 transfected HEK293T cells (lane 
1). The same blot was stripped and reprobed with anti-actin antibody (lower panel). LNX1 
was not detected in lanes loaded with homogenate from wild-type (lane 6) or KO (lane 7) 
small intestine, possibly due to inadequate protein loading. (B) LNX1 IP from tissue 
homogenates of wild-type or LNX1 KO mice and from lysates of LNX1p70- or LNX1p80-
transfected HEK293T cells using anti-LNX1 ab365 or rabbit IgG control, with immunoblots 
of IP material probed using anti-LNX1 ab8. Positive control IP shows migration profiles of 
LNX1 isoforms in IP material from the transfected HEK293T cells (lanes 9 and 10). Brain IP 
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material showed the presence of LNX1p70, but absence of LNX1p80 (lane 1). LNX1p80 but 
not LNX1p70 was detected in IP material of wild-type heart (lane 3), colon (lane 5) and 
kidney (lane 7), all of which as well as IP material of brain showed an absence of LNX1 
protein isoforms in LNX1 KO mice (lanes 2, 4, 6, 8). No bands were detected after control IP 
conducted with normal rabbit IgG using wild-type brain homogenate (lane 11), LNX1p70-
transfected HEK293T cell lysate (p80-nr; lane 12) or LNX1p80-transfected HEK293T cell 
lysate (p80-nr; lane 13). 
 
Fig. 6. Selective interaction of Cx36 with the second PDZ domain of LNX1, and requirement 
of Cx36 PDZ ligand for interaction. (A) Blot probed with anti-Cx36 after pull-down of Cx36 
from HeLa-Cx36 cells with PDZ domains of LNX1, showing detection of Cx36 after pull-
down with PDZ2 domain (lane 4), but not after pull-down with PDZ1 (lane 3), PDZ3 (lane 5) 
or PDZ4 (lane 6) domains of LNX1. The Cx36 pull-down band corresponds to Cx36 detected 
in lysates from HeLa-Cx36 cells (lane 1), which is absent in HeLa-WT (lane2). (B) The same 
blot as in (A) stripped and re-probed with anti-His (lanes 7-12) shows equivalent presence of 
the PDZ1-4 domains used for pull-downs (lanes 9-12), and absence of His-tag in HeLa-Cx36 
and HeLa-WT cells (lanes 7 and 8). (C) Blot probed with anti-Cx36 (lanes 1-5) shows pull-
down of Cx36 with the PDZ2 domain of LNX1 (lane 4) from lysates of HeLa-Cx36 cells, and 
lack of pull-down with PDZ2 from HeLa cells expressing Cx36 truncated of its 4 amino acid 
C-terminus PDZ ligand (trCx36; lane 5). Controls show detection of Cx36 (lane 2) and 
trCx36 (lane 3) in lysates from HeLa-Cx36 or HeLa-trCx36 cells, respectively, and absence 
of Cx36 in HeLa-WT cells (lane 1). (D) Lanes 4 and 5 were stripped and reprobed with anti-
His to show equal loading of the PDZ2 domain used for pull-down (lanes 6 and 7).  
 
Fig. 7. Selective interaction of Cx36 with the second PDZ domain of LNX2, and dependence 
on the PDZ ligand of Cx36 for interaction. (A) Blot probed with anti-Cx36 (lanes 1-6) shows 
detection of Cx36 in pull-down from lysate of N2A-Cx36 cells using the PDZ2 domain of 
LNX2 (lane 3), and absence of Cx36 pull-down from lysates of these cells using the PDZ1 
and PDZ4 domains of LNX2. Also absent is PDZ2 domain pull-down of Cx36 from N2A 
cells expressing Cx36 devoid of its PDZ ligand (trCx36) (lane 6). Controls show detection of 
Cx36 (lane 1) and trCx36 (lane 5) in transiently transfected N2A cells. A dimer form of Cx36 
was also detected (lanes 1, 3, and 5). (B) The same blot stripped and re-probed with anti-His 
(lanes 7-12) shows equivalent amounts of PDZ1, PDZ2 and PDZ4 domains of LNX2 used for 
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pull-downs (lanes 8, 9, 10 and 12). Lysates loaded in lanes 7 and 11 contain no His-tagged 
PDZ domain fusion protein. 
 
Fig. 8. Immunofluorescence localization of LNX proteins in Cx36-eCFP transfected N2A 
cells. (A) Cx36-eCFP fluorescence reveals large gap junctions at cell-cell contacts (arrows) 
and intracellular puncta (arrowheads). (B) Images of the same field of Cx36-eCFP-
transfected cells, showing co-localization of Cx36-eCFP fluorescence (B1) and 
immunolabelling of Cx36 (B2) at gap junctions (arrows) and intracellular structures 
(arrowheads), as seen by yellow in image overlay (B3, arrows). (C) Four images of the same 
field of cells co-transfected with Cx36-eCFP and LNX1p70, showing Cx36-eCFP 
fluorescence (C1), labelling of Cx36 (C2) and labelling of LNX1 (C3) intracellularly 
(arrows) and at gap junctions (arrows), and co- localization as seen by yellow in image 
overlay (C4, arrows). (D) Three images of the same field of cells co-transfected with Cx36-
eCFP and LNX1p80-FLAG, showing absence of Cx36-eCFP fluorescence (D1) and 
immunolabelling of Cx36 (D2) at cell contacts in cells immunolabelled for LNX1p80 (D3). 
(E) Cells transfected with LNX1p80-FLAG, showing co-distribution of immunolabelling 
with anti-FLAG (E1) and anti-LNX1 (E2). (F) Cells co-transfected with Cx36-eCFP (F1) and 
LNX2-FLAG (F2), showing absence of Cx36-eCFP at cell contacts. (G) Cells co-transfected 
with Cx36-eCFP and LNX2C51A-FLAG, showing intracellular and gap junctional eCFP 
fluorescence (arrows), which is co- localized with immunolabelling with anti-FLAG (arrows). 
 
Fig. 9. Immunoblot showing requirement of functional LNX2 RING domain for LNX2-
mediated ubiquitination of Cx36-eCFP. (A) IP of Cx36-eCFP with anti-eGFP from N2A cells 
co-transfected with Cx36-eCFP, HA-ubiquitin and either FLAG-vector, LNX2-FLAG or 
LNX2C51A-FLAG. IP material was immunoblotted and probed with anti-HA. Low baseline 
levels of ubiquitinated Cx36-eCFP were detected in IPs of cells co-transfected with FLAG-
vector (lane 1). An increase of HA-ubiquitinated Cx36-eCFP seen in IPs of cells co-
transfected with LNX2-FLAG (lane 2) was not seen in IPs from cells co-transfected with 
mutant LNX2C51A-FLAG (lane 3). Control IPs with normal rabbit IgG from lysates of cells 
co-transfected with LNX2-FLAG showed lack of detection of HA-ubiquitin (lane 4). (B) IgG 
heavy (IgG H-Chain) and light chains (IgG L-Chain) were revealed in images of TGX-stain-
free SDS-PAGE gels used for immunoblot shown in (A), indicating the equivalent amounts 
of IgG used for each IP (lanes 1-4 in A). (C) Immunoblot of input cell lysates used for IPs 
shown in (A) probed with anti-FLAG, showing detection of LNX2-FLAG (lane 2) and 
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LNX2C51A-FLAG (lane 3) in cells co-transfected with these constructs, and lack of FLAG 
detection in lysates from cells co-transfected with vector-FLAG (lane 1). (D) The blot in (C) 
was stripped and re-probed with anti-eGFP revealing decreased detection of Cx36-eCFP in 
lysates from cells co-transfected with LNX2 (lane 2) vs. those co-transfected with vector-
FLAG (lane 1) or LNX2C51AFLAG (lane 3). (E) Image of TGX-stain-free SDS-PAGE gel 
used to prepare immunoblots shown in C and D, indicating approximately equal protein 
sample loading. 
 
Fig. 10. Immunoblot of lysates from N2A cells probed with anti-Cx36 after co-transfection 
with Cx36-eCFP and either FLAG-vector, or wild-type LNX2-FLAG or mutant LNX2C51A-
FLAG lacking its RING domain.. (A) Cells were treated with lysosome inhibitors 
chloroquine or ammonium chloride as indicated. Cells transfected with Cx36-eCFP and 
empty FLAG-vector displayed a band migrating at ~60 kDa (lane 1), corresponding to the 
molecular weight of Cx36 plus eCFP, which was only faintly detected in Cx36-eCFP cells 
co-expressing LNX2-FLAG (lane 2), but was present in cells co-expressing LNX2C51A-FLAG 
(Lane 3). Detection of this band in cells expressing LNX2 was recovered after treatment with 
10-100 mM chloroquine (CQ; lanes 4-6) or with 25 mM ammonium chloride (NH4CL; lane 
7). Negative control lane shows absence of Cx36-eCFP in lysate of N2A cells transfected 
with only FLAG-vector (lane 8). (B) The blot shown in (A) was stripped and reprobed with 
anti-FLAG, showing presence of LNX2-FLAG and LNX2C51A-FLAG in correspondingly 
transfected cells (lanes 10-15), and its absence in cells not transfected with these constructs 
(lanes 9 and 16).  
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